As shown in Fig. 5b, 30 genes (e.g., EGFR, Casp8, Alox15 and Grm2) were found to be significantly up- or down-regulated exclusively in the Mix PD, thereby identifying them as candidate therapeutic targets for this subtype. This evidence concerns the gene MIXL1 and Parkinson disease.